علاج سرطان الشفة في المرحلة المبكرة (ورم T1 أو T2، 4 سم أو أصغر)

References

• The five-year crude survival rates for surgical treatment are about 75–80 per cent for T1 to T2 tumours, dropping to 40–50 per cent for T3 and T4 tumours.
• Early stage cancer can be treated equally well by surgery or radiation therapy.
• Small lesions are managed by simple surgical excision and primary closure.
• Equally good results can be achieved with fractionated EBRT or brachytherapy.
• External beam radiotherapy using electrons or orthovoltage photons minimises dose to the oral cavity so that mucositis occurs only on the treated lip.
• Iridium192 can be used in the treatment of lip cancer.
• Foscan® mediated PDT can also be used to treat primary cancer of the lip, where treatment yields complete response rates comparable with those published for surgery or RT.

DOI: 10.1017/S0022215116000499